• MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
  • Lymphocyte proliferation panel, Blood
  • MLH3 Gene Mutation Analysis
  • Amobarbital, Urine
  • Chromium, 24 Hour, Urine
  • Herpes Simplex Virus (HSV) 1 and 2 IgG
  • Phenosense HIV Drug Resistance Replication Capacity
  • Alpha Lactalbumin IgG
  • Measles (Rubeola) Antibody, IgM
  • Zika Virus IgM Antibody, IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Signatera™ for Minimal Residual Disease (MRD)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Signatera™ for Minimal Residual Disease (MRD)
Medical Test

Specimen Collection
Access to Signatera™ for Minimal Residual Disease (MRD) is restricted.